What Should Investors Make of Abbott's Reduced Full-Year Guidance?

·5-min read

COVID-19 testing ain't what it used to be. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli talk about what investors should make of Abbott's reduced guidance. Keith Speights: Abbott, ticker there is ABT, had some other news that wasn't so good.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting